Back
CRISPR Therapeutics AG Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
31
CRSP
CRISPR Therapeutics AG
Last Price:
$48.74
Seasonality Move:
2.01%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is moderately bearish and CRSP is experiencing selling pressure, which indicates risk of future bearish movement.
CRISPR Therapeutics AG Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 56.77 | Sell |
| 20-day SMA: | 55.36 | Sell |
| 50-day SMA: | 54.31 | Sell |
| 200-day SMA: | 55.45 | Sell |
| 8-day EMA: | 55.23 | Sell |
| 20-day EMA: | 52.33 | Sell |
| 50-day EMA: | 37.44 | Buy |
| 200-day EMA: | 13.57 | Buy |
CRISPR Therapeutics AG Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.96 | Buy |
| Relative Strength Index (14 RSI): | 40.99 | Sell |
| Chaikin Money Flow: | -5853677 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (49.65 - 58.39) | Sell |
| Bollinger Bands (100): | (50.87 - 61.61) | Sell |
CRISPR Therapeutics AG Technical Analysis
| Feb 26 | Feb 27 | Mar 2 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 9 | Mar 10 | Mar 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb | Mar | |||||||||
| 26 | 27 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for CRISPR Therapeutics AG Stock
Is CRISPR Therapeutics AG Stock a Buy?
-
CRISPR Therapeutics AG share price is 49.93 while CRSP 8-day simple moving average is 56.77, which is a Sell signal.
-
The stock price of CRSP is 49.93 while CRISPR Therapeutics AG 20-day SMA is 55.36, which makes it a Sell.
-
CRISPR Therapeutics AG 50-day simple moving average is 54.31 while CRSP share price is 49.93, making it a Sell technically.
-
CRSP stock price is 49.93 and CRISPR Therapeutics AG 200-day simple moving average is 55.45, creating a Sell signal.
CRSP Technical Analysis vs Fundamental Analysis
Sell
31
CRISPR Therapeutics AG (CRSP)
is a Sell
Is CRISPR Therapeutics AG a Buy or a Sell?
-
CRISPR Therapeutics AG stock is rated a SellThe current CRISPR Therapeutics AG [CRSP] share price is $49.93. The Score for CRSP is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
CRISPR Therapeutics AG Stock Info
Market Cap:
4.8B
Price in USD:
49.93
Share Volume:
6.3M
CRISPR Therapeutics AG 52-Week Range
52-Week High:
78.48
52-Week Low:
30.04
Sell
31
CRISPR Therapeutics AG (CRSP)
is a Sell
CRISPR Therapeutics AG Share Price Forecast
-
What is the CRISPR Therapeutics AG stock price today?The CRISPR Therapeutics AG stock price is 49.93 USD today.
-
Will CRSP stock go up or go down?CRISPR Therapeutics AG> share price is forecast to RISE/FALL based on technical indicators
-
Is CRISPR Therapeutics AG overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, CRISPR Therapeutics AG is overvalued.
Is CRISPR Therapeutics AG Stock a Buy?
-
CRISPR Therapeutics AG share price is 49.93 while CRSP 8-day exponential moving average is 55.23, which is a Sell signal.
-
The stock price of CRSP is 49.93 while CRISPR Therapeutics AG 20-day EMA is 52.33, which makes it a Sell.
-
CRISPR Therapeutics AG 50-day exponential moving average is 37.44 while CRSP share price is 49.93, making it a Buy technically.
-
CRSP stock price is 49.93 and CRISPR Therapeutics AG 200-day simple moving average is 13.57, creating a Buy signal.
Fundamental Analysis of CRISPR Therapeutics AG
Is CRISPR Therapeutics AG a good investment?
-
Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $0.15 per share, an increase this year of $1.22 per share, and an increase next year of $0.74 per share.
Technical Analysis of CRISPR Therapeutics AG
Should I short CRISPR Therapeutics AG stock?
-
CRSP Moving Average Covergence Divergence (MACD) indicator is 5.96, suggesting CRISPR Therapeutics AG is a Buy
-
CRISPR Therapeutics AG Relative Strength Index (RSI) is 40.99, which suggest CRISPR Therapeutics AG is oversold
-
The Bollinger Bands (25) for CRISPR Therapeutics AG is (49.65 - 58.39), which suggest CRISPR Therapeutics AG is a Sell
-
The Bollinger Bands (100) for CRISPR Therapeutics AG is (50.87 - 61.61), which suggest CRISPR Therapeutics AG is a Sell
* CRISPR Therapeutics AG stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.